Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine and Cetuximab in Second-Line Stage IIIB/IV NSCLC
NCT00519831Phase 2Terminated
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Aug 2007
- Primary completion
- Feb 2008
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vinflunine in non-small cell lung cancer (NSCLC), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Aug 2007; status: terminated.
02
Drugs
vinflunine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00519831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519831.